Stay updated on ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial
Sign up to get notified when there's something new on the ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial page.

Latest updates to the ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page’s displayed software/version “Revision” updates from v3.5.2 to v3.5.3 without changing the study record history content.SummaryDifference0.1%

- Check15 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the study record history.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedRecord History now includes a new Revision: v3.5.0 and removes Revision: v3.4.3.SummaryDifference0.1%

- Check51 days agoChange DetectedThe history now includes a new revision entry v3.4.3. The previous revision v3.4.2 is removed.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision: v3.4.2 was added to the history. The site-wide government funding notice was removed from the page.SummaryDifference0.8%

- Check87 days agoChange DetectedA government funding lapse notice was added along with the new revision label Revision: v3.4.1, and the previous revision label Revision: v3.4.0 was removed.SummaryDifference0.8%

Stay in the know with updates to ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial page.